A multicenter study of new anticancer agent for patients with advanced hepatocellular carcinoma : efficacy and safety
Not Applicable
- Conditions
- Hapatocellular carcinoma
- Registration Number
- JPRN-UMIN000002394
- Lead Sponsor
- Kanazawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
1) Contraindication of new anticancer agent 2) The investigator consider not suitable for the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety of new anti-cancer agents : Incidence of adverse event
- Secondary Outcome Measures
Name Time Method Efficacy of new anti-cancer agents : Overall survival, progression-free survival, time to disease progression, overall response rate